Post-transfusion platelet responses in critically ill cancer patients with hypoproliferative thrombocytopenia

被引:14
作者
Baron, Elodie [1 ]
Charpentier, Julien [1 ]
Francois, Anne [2 ]
Ben Hadj Amor, Habib [2 ]
Habr, Bassem [3 ]
Cariou, Alain [1 ,4 ]
Chiche, Jean-Daniel [1 ,4 ,5 ]
Mira, Jean-Paul [1 ,4 ,5 ]
Jamme, Matthieu [6 ,7 ]
Pene, Frederic [1 ,4 ,5 ]
机构
[1] Hop Univ Paris Ctr, Hop Cochin, Assistance Publ Hop Paris, Med Intens & Reanimat, Paris, France
[2] Etab Francais Sang, La Plaine St Denis, France
[3] Univ Paris 05, Paris, France
[4] CNRS, UMR8104, Inst Cochin, INSERM,U1016, Paris, France
[5] Hop Poissy St Germain, Reanimat Medicochirurg, Poissy, France
[6] Univ Versailles St Quentin, Team 5 EpReC Renal & Cardiovasc Epidemiol, CESP, INSERM,U1018, Villejuif, France
[7] Univ St Joseph, Beirut, Lebanon
关键词
INTENSIVE-CARE-UNIT; TRANSFUSION; REFRACTORINESS; MULTICENTER; INCREMENTS; FREQUENCY; DECLINE; SCORE;
D O I
10.1111/trf.15596
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Platelet transfusion is aimed at increasing platelet counts to prevent or treat bleeding. Critically ill cancer patients with hypoproliferative thrombocytopenia are high consumers of blood products. We herein described their post-transfusion platelet responses in the intensive care unit (ICU) and analyzed the determinants of poor post-transfusion increments. STUDY DESIGN AND METHODS This was a single-center 9-year (2009-2017) retrospective observational study. Patients with malignancies and presumed or proven hypoproliferative thrombocytopenia who had received at least one platelet transfusion in the ICU were included. Poor post-transfusion platelet increments were defined as body surface-adjusted corrected count increment (CCI) <7, or alternatively as weight-adjusted platelet transfusion recovery (PTR) <0.2. Patients were deemed refractory to platelet transfusions when two consecutive ABO-compatible transfusions resulted in poor platelet increments. RESULTS A total of 1470 platelet transfusions received by 326 patients were analyzed. Indications for platelet transfusions were distributed into prophylactic (44.5%), peri-procedural (18.1%) and therapeutic (37.4%). Regardless of indications, 54.6% and 55.4% of transfusion episodes were associated with a CCI <7 or a PTR <0.2. Factors independently associated with poor post-transfusion increments were lower body mass index, spleen enlargement, concurrent severity of clinical condition, fever >= 39 degrees C, antibiotic therapy and increased storage duration of platelet concentrates. Eventually, 48 patients developed refractoriness to platelet transfusion, which was associated increased incidence of bleeding events. CONCLUSION Platelet transfusions are often associated with poor increments in critically ill cancer patients with hypoproliferative thrombocytopenia. The findings suggest amenable interventions to improve the platelet transfusion practices in this setting.
引用
收藏
页码:275 / 284
页数:10
相关论文
共 36 条
  • [1] Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigations
    Antier, Nadiejda
    Quenot, Jean-Pierre
    Doise, Jean-Marc
    Noel, Robin
    Demaistre, Emmanuel
    Devilliers, Herve
    [J]. ANNALS OF INTENSIVE CARE, 2014, 4 : 1 - 7
  • [2] Arnold DM, 2006, TRANSFUSION, V46, P1286, DOI 10.1111/j.1537-2995.2006.00892.x
  • [3] Platelet storage duration and its clinical and transfusion outcomes: a systematic review\
    Aubron, Cecile
    Flint, Andrew W. J.
    Ozier, Yves
    McQuilten, Zoe
    [J]. CRITICAL CARE, 2018, 22
  • [4] Linear decline of corrected platelet count increment within 24hours after platelet transfusion in haematological patients: A prospective observational study
    Benediktsson, Sigurdur
    Lazarevic, Vladimir
    Nilsson, Lars
    Kjeldsen-Kragh, Jens
    Schott, Ulf
    Kander, Thomas
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (06) : 559 - 568
  • [5] Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions
    Bercovitz, Rachel S.
    O'Brien, Sarah H.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, : 157 - 160
  • [6] Age of platelet concentrates and time to the next transfusion
    Caram-Deelder, Camila
    van der Bom, Johanna G.
    Putter, Hein
    Leyte, Anja
    van de Kerkhof, Daan
    Evers, Dorothea
    Beckers, Erik A.
    Weerkamp, Floor
    Hudig, Francisca
    Zwaginga, Jaap Jan
    Rondeel, Jan M. M.
    de Vooght, Karen M. K.
    Pequeriaux, Nathalie C. V.
    Visser, Otto
    Wallis, Jonathan P.
    Middelburg, Rutger A.
    [J]. TRANSFUSION, 2018, 58 (01) : 121 - 131
  • [7] Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation
    Estcourt, Lise
    Stanworth, Simon
    Doree, Carolyn
    Hopewell, Sally
    Murphy, Michael F.
    Tinmouth, Alan
    Heddle, Nancy
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (05):
  • [8] Guidelines for the use of platelet transfusions
    Estcourt, Lise J.
    Birchall, Janet
    Allard, Shubha
    Bassey, Stephen J.
    Hersey, Peter
    Kerr, Jonathan Paul
    Mumford, Andrew D.
    Stanworth, Simon J.
    Tinegate, Hazel
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (03) : 365 - 394
  • [9] Duration of platelet storage and outcomes of critically ill patients
    Flint, Andrew
    Aubron, Cecile
    Bailey, Michael
    Bellomo, Rinaldo
    Pilcher, David
    Cheng, Allen C.
    Hegarty, Colin
    Reade, Michael C.
    McQuilten, Zoe
    [J]. TRANSFUSION, 2017, 57 (03) : 599 - 605
  • [10] Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients?
    Friedmann, AM
    Sengul, H
    Lehmann, H
    Schwartz, C
    Goodman, S
    [J]. TRANSFUSION MEDICINE REVIEWS, 2002, 16 (01) : 34 - 45